I’ve been working with the British Society for Immunology (BSI) to develop a new online training course on IBD immunology in clinical practice. The first gastroenterology day is on 5th June; details 👉bit.ly/3x2jEEV BSI Congress & Events JimBrewer Nikolas Plevris Beatriz Gros

Upadacitinib for Crohn's disease • data from Edinburgh and Exeter • n=93 with median 25w follow-up • effective in highly refractory cohort See 👇 for figures and link Frontline Gastro

JAK-STAT pathways can be complex to understand, gaining insight into their functions helps us comprehend the consequences of their blockade. Bearing this in mind, I have done a summary attempting to synthesize this complexity focusing on #IBD therapies, I hope it proves useful.

PhD available! We've genotyped thousands of patients with IBD and linked them to lifelong healthcare registry data. We want to go beyond susceptibility genetics and looking for a talented student to combine genomics, ML & epidemiology stillinger.aau.dk/phd-stillinger… #PhDjobs #PhDposition

Individually we are a drop, together we are an ocean Charlie Lees Nathan Constantine-Cooke Nikolas Plevris Gareth-Rhys Jones #Chiara #Lisa #Solomon And missing people in the picture Lauranne Derikx #Alex

A few photos I took with the team on Thursday morning Beatriz Gros Nathan Constantine-Cooke Nikolas Plevris

📢 On World #IBD Day weekend Carl Anderson and I are delighted to introduce Open-IBD! £11M funding from Open Targets and Wellcome Sanger Institute Open-IBD will study serial multi-omics and longterm outcomes from diagnosis in 1,000 people with IBD More👇 opentargets.org/news/open-ibd-…

I’m going to start the field of omic-omics, studying the rate of things being called omics that should not be called omics. By 2030 every word in medical dictionaries will have an omic equivalent.

Missing the rest of the team but here we are representing the Edinburgh #IBD unit Cannot explain how much I miss seeing these faces every day Charlie Lees Nathan Constantine-Cooke Alex Elford Digestive Disease Week #DDW2024

Enjoying day 3 of #DDW2024

Flying home from #DDW2024 full of positive energy and great ideas Amazing people from across the world - clinicians, scientists, tech and industry- working together to improve patient outcomes.

Outstanding work and team, and what is more, the data coming from this are highly relevant to a better understanding of #IBD flares 🤩🤩 thanks Charlie Lees for leading us all

JOB OPPORTUNITY We are looking for a band 6 clinical research nurse to work on our portfolio of IBD studies 2-year contract in first instance Come join us at The University of Edinburgh NHS Lothian jobs.ac.uk/job/DIS441/res…

Our study at Therapeutic Advances in Gastroenterology Long-term outcomes & predictors of vedolizumab persistence in #UC ✅ persistence exceeding 80% at 1y and 50% at 5y 🌟 previous exposure to biologics/small molecules, disease distribution & steroid at baseline influenced persistence ✅ no new

I feel deeply honored to be in this list together with these amazing people Thank you in advance if you vote for me to be awarded 🙏🏻🙏🏻

Job Opportunity: Postdoctoral Research Associate in Health Data Science Location: Edinburgh, UK Institute of Genetics and Cancer Centre for Genomic and Experimental Medicine The University of Edinburgh We’re looking for a passionate Postdoctoral Research Associate to join our dynamic team focused on building predictive models for inflammatory

Great to have Charlie Lees and Nathan Constantine-Cooke from Institute of Genetics and Cancer The University of Edinburgh visiting PREDICT IBD this week to discuss collaborative studies on differences in trajectories of patients with IBD. Danmarks Grundforskningsfond Aalborg Universitet AAU SUND Aalborg Universitetshospital Tine Jess

An enormous privilege to be visiting the smart, driven, and lovely people at PREDICT this week to collaborate on exciting work characterising heterogeneity in IBD.